Benserazide

Indications	Oral Parkinson's disease *Adult:* Usually given with L-dopa in the ratio of 1 part of benserazide base to 4 parts of L-dopa. As capsule containing levodopa 100 mg and benserazide 25 mg: Initially, 1 capsule 1-2 times/day; increase every 3-4 days until therapeutic effect; optimal dosage: 4-8 capsules/day, given in 4-6 divided doses. Max (per day): Levodopa 1200 mg/ benserazide 300 mg.
Contraindications	Avoid in patients <25 yr, pregnancy or women of child-bearing potential in the absence of adequate contraception.
Mechanism of Actions	It is a peripheral dopa-decarboxylase inhibitor with little or no pharmacological activity when used alone. It inhibits peripheral decarboxylation of L-dopa to dopamine, thus effective brain concentrations of dopamine are produced with lower doses of L-dopa. It is used as an adjunct to levodopa in the treatment of parkinsonism. Absorption: Rapidly absorbed (approx 58%). Concurrent admin with L-dopa increases the absorption slightly. Metabolism: Mainly metabolised in the gut. Excretion: Rapidly excreted as metabolites in the urine mostly within the 1st 6 hr; 85% excretion within 12 hr.
Storage Conditions	Oral: Store at 15-30°C.
Storage	Oral: Store at 15-30°C.
Available As	Benserazide 25 mg Benserazide 28.5 mg Benserazide 50 mg

Subscribe to our e-mail newsletter to receive updates.

Benserazide Containing Brands

We are Developing Our database, More results coming soon.

Benserazide is used in following diseases

We are Developing Our database, More results coming soon.

Drug - Drug Interactions of Benserazide

We are Developing Our database, More results coming soon.